Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 5009.90, up by 60.10 points or 1.21% from its previous closing of Rs. 4949.80 on the BSE.

The scrip opened at Rs. 4935.00 and has touched a high and low of Rs. 5041.60 and Rs. 4892.80 respectively. So far 28444 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 2497.60 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 5148.00 and Rs. 4832.40 respectively. The current market cap of the company is Rs. 83066.84 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.50% and 15.6% respectively.

Dr. Reddy's Laboratories has reported 64.76% fall in its net profit of Rs 481.00 crore for the quarter ended September 30, 2020 as against net profit of Rs 1365.10 crore for the same quarter in the previous year. Total income of the company decreased 4.27% at Rs 3,372.40 crore for Q2FY21 as compared Rs 3,522.70 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 30.27% fall in its net profit of associate at Rs 771.80 crore for the quarter ended September 30, 2020 as against net profit of Rs 1106.80 crore for the same quarter in the previous year. However, total income of the company increased by 1.96% at Rs 4,962.10 crore for Q2FY21 as compared Rs 4,866.80 crore for the corresponding quarter previous year.